bendamustine hydrochloride has been researched along with Lymphoproliferative Disorders in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Lin, X; Xu, Q; Yu, J; Zhang, K | 1 |
| Bareau, B; Baugier de Materre, A; Bene, MC; Chaoui, D; Dartigeas, C; Dupuis, J; Eveillard, JR; Herbaux, C; Laribi, K; Le Calloch, R; Leblond, V; Merabet, F; Poulain, S; Roos-Weil, D; Roussel, X; Tricot, S; Willems, L | 1 |
| Avigdor, A; Aviv, A; Avivi, I; Gafter-Gvili, A; Gurion, R; Kedmi, M; Mizrahi, N; Nagler, A; Perry, C; Raanani, P; Ram, R; Ribakovsky, E; Vidal, L | 1 |
| Berentsen, S | 1 |
| Kalaycio, M | 1 |
| Nagi, J; Tageja, N | 1 |
| Montillo, M; Morra, E; Ricci, F; Tedeschi, A; Vismara, E | 1 |
| Fiegl, M; Gastl, G; Hager, J; Oexle, H; Schnallinger, M; Schreieck, S; Stauder, R; Verdorfer, I; Waldthaler, C; Zabernigg, A; Zangerl, G | 1 |
4 review(s) available for bendamustine hydrochloride and Lymphoproliferative Disorders
| Article | Year |
|---|---|
Cold agglutinin disease.
Topics: Anemia, Hemolytic, Autoimmune; B-Lymphocytes; Bendamustine Hydrochloride; Complement C3b; Humans; Lymphoproliferative Disorders; Rituximab | 2016 |
Bendamustine: a new look at an old drug.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Drug Resistance, Neoplasm; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Nitrogen Mustard Compounds | 2009 |
Bendamustine: something old, something new.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bendamustine Hydrochloride; Drug Synergism; Humans; Leukemia; Lymphoma; Lymphoproliferative Disorders; Nitrogen Mustard Compounds; Remission Induction; Rituximab | 2010 |
Bendamustine: new perspective for an old drug in lymphoproliferative disorders.
Topics: Antineoplastic Agents; Bendamustine Hydrochloride; Clinical Trials as Topic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Nitrogen Mustard Compounds | 2010 |
4 other study(ies) available for bendamustine hydrochloride and Lymphoproliferative Disorders
| Article | Year |
|---|---|
CB-LPD, MGUS, T-LGLL, and PRCA: A rare case report of 4 concomitant hematological disorders.
Topics: Aged; Anemia; Antineoplastic Agents; Bendamustine Hydrochloride; Bortezomib; Dexamethasone; Humans; Leukemia, Large Granular Lymphocytic; Lymphoproliferative Disorders; Male; Monoclonal Gammopathy of Undetermined Significance; Red-Cell Aplasia, Pure; Rituximab; Sirolimus | 2021 |
Bendamustine plus rituximab in newly-diagnosed Waldenström macroglobulinaemia patients. A study on behalf of the French Innovative Leukaemia Organization (FILO).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Female; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Rituximab; Waldenstrom Macroglobulinemia | 2019 |
Infections associated with bendamustine containing regimens in hematological patients: a retrospective multi-center study.
Topics: Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Biomarkers; Female; Hematologic Diseases; Hospitalization; Humans; Incidence; Infections; Israel; Lymphoproliferative Disorders; Male; Middle Aged; Retrospective Studies; Risk Factors | 2016 |
Routine use of bendamustine and rituximab combination therapy in consecutive patients with lymphoproliferative diseases: a survey from Tyrolean hospitals.
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Austria; Bendamustine Hydrochloride; Child; Cohort Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Infant; Kaplan-Meier Estimate; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Nitrogen Mustard Compounds; Opportunistic Infections; Pancytopenia; Retrospective Studies; Rituximab; Treatment Outcome | 2011 |